Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2017

Open Access 01-12-2017 | Research article

The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance

Authors: Xinfeng Yan, Peicheng Li, Zhaosheng Tang, Bo Feng

Published in: BMC Endocrine Disorders | Issue 1/2017

Login to get access

Abstract

Background

Recent studies show that bile acids are involved in glucose and energy homeostasis through activation of G protein coupled membrane receptor (TGR5) and farnesoid X receptor (FXR). A few researches have explored changes of TGR5 and FXR in animals with impaired glucose regulation. This study aimed to observe changes of plasma total bile acids (TBA), glucagon-like-peptide 1 (GLP-1), fibroblast growth factor 15 (FGF15), intestinal expressions of TGR5 and FXR, and correlations between them in rats with glucose intolerance.

Methods

Besides plasma fasting glucose, lipid, TBAs, alanine transaminase (ALT), active GLP-1(GLP-1A) and FGF15, a postprandial meal test was used to compare responses in glucose, insulin and GLP-1A among groups. The expressions of TGR5 and FXR in distal ileum and ascending colon were quantified by real-time PCR and western blot.

Results

TGR5 expression was significantly decreased in distal ileum in DM group compared to other groups, and TGR5 and FXR expressions in ascending colon were also decreased in DM group compared to other groups. Correlation analysis showed correlations between TBA and GLP-1A or FGF15. GLP-1A was correlated with TGR5 mRNA expression in colon, and FGF15 was correlated with FXR mRNA expression in colon.

Conclusions

These results indicates that bile acid-TGR5/FXR axis contributes to glucose homeostasis.
Literature
1.
go back to reference Hofmann AF, Hagey LR. Bile acids:Chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci. 2008;65:2461–83.CrossRefPubMed Hofmann AF, Hagey LR. Bile acids:Chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci. 2008;65:2461–83.CrossRefPubMed
2.
go back to reference Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science. 1999;284:1365–8.CrossRefPubMed Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science. 1999;284:1365–8.CrossRefPubMed
3.
go back to reference Kim I, Ahn SH, Inagaki T, Choi M, Ito S, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 2007;48:2664–72.CrossRef Kim I, Ahn SH, Inagaki T, Choi M, Ito S, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 2007;48:2664–72.CrossRef
4.
go back to reference Potthoff MJ, Potts A, He T, Duarte JA, Taussig R, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol. 2013;304:G371–80.CrossRefPubMed Potthoff MJ, Potts A, He T, Duarte JA, Taussig R, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol. 2013;304:G371–80.CrossRefPubMed
5.
go back to reference Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278:9435–40.CrossRefPubMed Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278:9435–40.CrossRefPubMed
6.
go back to reference Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun. 2005;329:386–90.CrossRefPubMed Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun. 2005;329:386–90.CrossRefPubMed
8.
go back to reference Orskov C, Holst JJ, Nielsen OV. Effect of truncated glucagon-like peptide-1 [proglucagon-(78–107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology. 1988;123:2009–13.CrossRefPubMed Orskov C, Holst JJ, Nielsen OV. Effect of truncated glucagon-like peptide-1 [proglucagon-(78–107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology. 1988;123:2009–13.CrossRefPubMed
9.
10.
go back to reference Feigh M, Hjuler ST, Andreassen KV, et al. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats. Eur J Pharmacol. 2014;737:91–6.CrossRefPubMed Feigh M, Hjuler ST, Andreassen KV, et al. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats. Eur J Pharmacol. 2014;737:91–6.CrossRefPubMed
11.
go back to reference Zhou YS, G Y, Li B, Liu DG, Chi JM, et al. (2005) A rat model of type 2 diabetes mellitus induced by high fat chow and low dose streptozocin injection. Acta Laboratorium Animals Scientia Sinica 13: 154–158. Zhou YS, G Y, Li B, Liu DG, Chi JM, et al. (2005) A rat model of type 2 diabetes mellitus induced by high fat chow and low dose streptozocin injection. Acta Laboratorium Animals Scientia Sinica 13: 154–158.
12.
go back to reference Yang JL, Li G, Liu YP, Zhang FL, Cui JL, et al. Establishing a rat model similar to the adult patient of the general type 2 diabetes by long-term fat-enriched fed and lower dose of streptozocin-treated rats. Acta Laboratorium Animals Scientia Sinica. 2003;11:138–41. Yang JL, Li G, Liu YP, Zhang FL, Cui JL, et al. Establishing a rat model similar to the adult patient of the general type 2 diabetes by long-term fat-enriched fed and lower dose of streptozocin-treated rats. Acta Laboratorium Animals Scientia Sinica. 2003;11:138–41.
13.
go back to reference Roberts RE, Glicksman C, Alaghband-Zadeh J,etc. (2011) The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol(Oxf) 74(1):67–72. Roberts RE, Glicksman C, Alaghband-Zadeh J,etc. (2011) The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol(Oxf) 74(1):67–72.
14.
go back to reference LiVak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–8.CrossRefPubMed LiVak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–8.CrossRefPubMed
15.
go back to reference Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, et al. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J BiolChem. 2003;278:39422–7. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, et al. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J BiolChem. 2003;278:39422–7.
16.
go back to reference Wu YL, Zhao BZ, Xi GX, Gao CH. An experimental study of impaired glucose tolerance in Wistar rats. Chinese Remedies & Clinics. 2007;7:281–3. Wu YL, Zhao BZ, Xi GX, Gao CH. An experimental study of impaired glucose tolerance in Wistar rats. Chinese Remedies & Clinics. 2007;7:281–3.
17.
go back to reference Gupta S, Stravitz RT, Dent P, Hylemon PB. Down-regulation of cholesterol 7a-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem. 2001;276:15816–22.CrossRefPubMed Gupta S, Stravitz RT, Dent P, Hylemon PB. Down-regulation of cholesterol 7a-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem. 2001;276:15816–22.CrossRefPubMed
18.
go back to reference Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, et al. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br JPharmacol. 2012;165:414–23.CrossRef Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, et al. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br JPharmacol. 2012;165:414–23.CrossRef
19.
go back to reference Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6:7629.CrossRefPubMedPubMedCentral Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6:7629.CrossRefPubMedPubMedCentral
20.
go back to reference Adrian TE, Ballantyne GH, Longo WE, Bilchik AJ, Graham S, et al. Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut. 1993;34:1219–24.CrossRefPubMedPubMedCentral Adrian TE, Ballantyne GH, Longo WE, Bilchik AJ, Graham S, et al. Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut. 1993;34:1219–24.CrossRefPubMedPubMedCentral
21.
go back to reference Thomas C, Auwerx J, Schoonjans K. Thyroid economy – regulation, cell biology, thyroid hormone metabolism and action: the special edition:metabolic effects of thyroid hormones. Thyroid. 2008;18:167–74.CrossRefPubMed Thomas C, Auwerx J, Schoonjans K. Thyroid economy – regulation, cell biology, thyroid hormone metabolism and action: the special edition:metabolic effects of thyroid hormones. Thyroid. 2008;18:167–74.CrossRefPubMed
22.
go back to reference Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism. 2013;17:225–35.CrossRefPubMed Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism. 2013;17:225–35.CrossRefPubMed
23.
go back to reference Parséus A, Sommer N, Sommer F, Caesar R, Molinaro A, et al.(2016) Microbiota-induced obesity requires farnesoid X receptor. Gut 0:1–9. Parséus A, Sommer N, Sommer F, Caesar R, Molinaro A, et al.(2016) Microbiota-induced obesity requires farnesoid X receptor. Gut 0:1–9.
Metadata
Title
The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance
Authors
Xinfeng Yan
Peicheng Li
Zhaosheng Tang
Bo Feng
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2017
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-017-0211-5

Other articles of this Issue 1/2017

BMC Endocrine Disorders 1/2017 Go to the issue